Terms ending in 2032
Every in-force patent on Surmodics, Inc.'s record whose computed term ends in 2032, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 9,522,266 | Hemostasis Sealing Device In force · High confidence | Surmodics MD, LLC | In force | High confidence | |
| US 10,835,731 | Hemostasis Sealing Device In force · High confidence | Surmodics MD, LLC | In force | High confidence | |
| US 8,668,667 | Double Wall Catheter for Delivering Therapeutic Agent In force · High confidence | Surmodics MD, LLC | In force | High confidence | |
| US 8,889,760 | Photoactivatable Crosslinker In force · High confidence | Surmodics Coatings, LLC | In force | High confidence | |
| US 8,951,973 | Controlled-Released Peptide Formulations In force · High confidence | Surmodics Coatings, LLC | In force | High confidence | |
| US 8,459,310 | Systems and Methods for Filling Medical Device Lumen In force · High confidence | Surmodics MD, LLC | In force | High confidence | |
| US 10,058,634 | Devices and Methods for Delivery of Bioactive Agents In force · High confidence | Surmodics Coatings, LLC | In force | High confidence | |
| US 9,757,497 | Delivery of Coated Hydrophobic Active Agent Particles In force · High confidence | Surmodics MD, LLC | In force | High confidence | |
| US 9,861,727 | Delivery of Hydrophobic Active Agent Particles In force · High confidence | Surmodics MD, LLC | In force | High confidence | |
| US 10,213,528 | Delivery of Hydrophobic Active Agent Particles In force · High confidence | Surmodics MD, LLC | In force | High confidence | |
| 8 more term ends in 2032 · Pro | |||||
10 of 18 patents shown. Soonest term end first, then patent number.
Pro members see all 18.
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.